Articles
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Hagström E, Steg PG, Szarek M, et al.
Journal:
Circulation
First published: June 30, 2022 DOI: 10.1161/CIRCULATIONAHA.121.057807
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
ConfirmHagström E, Steg PG, Szarek M, et al.
Circulation
First published: June 30, 2022 DOI: 10.1161/CIRCULATIONAHA.121.057807